News and Trends 13 May 2019 Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks …the Series A money will help Treefrog to automate its stem cell production process by 2021. The round will also fund the development of a stem cell therapy for Parkinson’s… May 13, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2017 Biotech from the Bermuda Islands Brings Good News for Dementia Patients …Parkinson’s disease dementia (PDD). Based on these positive preliminary results, the biotech is getting ready to recruit more patients and prepare for Phase III, which is expected to start in… February 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Sep 2024 Estonia: Seven biotech companies to reckon with …RNA modifications to address these diseases. The company’s lead drug candidate, CHMA1004, is currently in the preclinical stage and is being developed to treat Parkinson’s disease, depression, anxiety, and post-traumatic… September 17, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 30 Oct 2017 French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy, Parkinson’s, Alzheimer’s and neuropathic pain. Theranexus, based in Lyon, starts… October 30, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 31 Jan 2017 Biologicals on the Brain: Biotech in Neurodegenerative Disease …Phase II trials and AFFiRiS, a Vienna-based biotech that currently has a Parkinson’s vaccine in a Phase 1b trial. “Our therapeutic is aimed at teaching the body to produce the… January 31, 2017 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 May 2017 In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight …Swiss Exchange, works in a mostly virtual biotech model and is carrying on clinical programs on Parkinson’s Disease and epilepsy with some high-profile partnerships, including Janssen and the Michael J…. May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Podcast 15 Mar 2024 Reformulating psychedelics for neurodegenerative diseases …are conditions where the trip may be useful, conditions that are based on life trauma, such as PTSD,” Clark explained. Idazoxan’s journey from Parkinson’s to schizophrenia Idazoxan, which Terran Biosciences… March 15, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Startup Scout 13 Oct 2017 This French Biotech is Taking On CNS Diseases of the Young and the Elderly This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis… October 13, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2016 World Mental Health Day: How is Biotech Helping the Cause? …Alzheimer’s, while Parkinson’s affects 6.3 million people. Current treatments deal with symptoms but cannot stop the progression of the disease. We interviewed the CSO of the Dementia Discovery Fund earlier… October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Apr 2018 Major $115M Fundraising Fuels AI Drug Development …diseases such as motor neuron disease and Parkinson’s that have been difficult to understand and treat up until now. Specifically, the technology can identify the molecular signs of a disease… April 19, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2022 Watch: IRLAB CEO Richard Godfrey IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company’s most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in phase IIb and are… December 20, 2022 - 1 minutemin - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Oct 2025 Biotech in Luxembourg: five companies that have made their name …In a bid to identify drug targets and develop candidates for the treatment of Parkinson’s disease, OrganoTherapeutics has created human-specific mini-brains, which represents the pathology of the disease. With a… October 15, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email